Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Keryx CEO: Selling Company 'Top Priority'
TheStreet.com
Thursday, September 8, 2011 - 11:14am
tags:
Keryx, M&A, colon cancer, perifosine
Sanofi: Another Encouraging Announcement
Seeking Alpha
Thursday, September 8, 2011 - 11:13am
tags:
Sanofi
FDA Approval Process Sets Higher Bar For What's Treatable
Seeking Alpha
Thursday, September 8, 2011 - 11:12am
tags:
FDA, AstraZeneca, JNJ, Perrigo Company, Regeneron, generics
Gilead Amends HCV Combo Study
Yahoo/Zacks.com
Thursday, September 8, 2011 - 11:11am
tags:
HCV, Gilead, hepatitis C, JNJ, GS 9190
Risk-Reward Balanced at MannKind
Yahoo/Zacks.com
Wednesday, September 7, 2011 - 1:07pm
tags:
MannKind, diabetes, Afrezza, inhaled insulin
BioMarin Evenly Poised
Yahoo/Zacks.com
Wednesday, September 7, 2011 - 1:06pm
tags:
Biomarin, Pfizer, Sanofi, Kuvan, Aldurazyme, Naglazyme, Firdapse
FierceBiotech's 2011 Fierce 15 Biotech Companies
Fierce Biotech
Wednesday, September 7, 2011 - 11:28am
tags:
Blueprint Medicines, Cerulean, Cerenis Therapeutics, Epizyme, Forma Therapeutics, Intrexon, Merrimack Pharmaceuticals, f-star, Pfenex, Pearl Therapeutics, Reata, Selecta, Rib-X Pharmaceuticals, Tesaro, Theraclone
f-star lands $708M antibody pact with Merck Serono
Fierce Biotech
Wednesday, September 7, 2011 - 11:25am
tags:
antibodies, f-star, Merck Serono
Par Pharmaceutical Engaged in Illegal Drug-Switching Scheme, U.S. Says
Bloomberg
Wednesday, September 7, 2011 - 11:24am
tags:
drug swap laws, Par Pharmaceutical, generics, False Claims Act
Teva defense of Copaxone starts today
Pharma Times, UK
Wednesday, September 7, 2011 - 11:20am
tags:
Teva Pharmaceuticals, Copaxone, MS, multiple sclerosis, patents
WHO Should Buy Diabetes Drugs in Bulk for Poor Nations, Novo Nordisk Says
Bloomberg
Wednesday, September 7, 2011 - 11:18am
tags:
WHO, Novo Nordisk, diabetes
AstraZeneca pushes research makeover
Boston.com, MA
Wednesday, September 7, 2011 - 11:16am
tags:
AstraZeneca, R&D
Dynavax Receives $600,000 SBIR Grant for TLR Research
Yahoo/Marketwire
Wednesday, September 7, 2011 - 11:10am
tags:
grant, Dynavax, PI3K
Off-Label Avastin Use, Medicare And Saving Money
Pharmalot
Wednesday, September 7, 2011 - 9:54am
tags:
Medicare, off-label, Avastin, Roche, Genentech, age-related macular degeneration
Sanofi’s PowerPoint of Doom Shows 9,500 Layoffs by the End of the Year
BNET Pharma
Wednesday, September 7, 2011 - 9:51am
tags:
Sanofi, layoffs
1 Reason the Street Should Expect Big Things From ViroPharma
Motley Fool
Wednesday, September 7, 2011 - 9:49am
tags:
ViroPharma, Gilead, Cubist Pharmaceuticals, Salix
BioDelivery Sciences reports positive Phase 1 drug results
Bizjournals.com
Wednesday, September 7, 2011 - 9:48am
tags:
BioDelivery Sciences, BEMA Buprenorphine/Naloxone, drug abuse
Biogen will buy Italy, Switzerland joint ventures
Yahoo/AP
Wednesday, September 7, 2011 - 9:46am
tags:
Biogen Idec, Italy, Switzerland, Dompe Group
ViroPharma receives European Union approval for pediatric epileptic seizure treatment
Yahoo/AP
Wednesday, September 7, 2011 - 9:45am
tags:
Europe, ViroPharma, epilepsy
Amag-Allos Merger in Jeopardy
TheStreet.com
Wednesday, September 7, 2011 - 9:43am
tags:
Allos, Amag Pharmaceuticals, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.